Search details
1.
Discovery of ethyl ketone-based HDACs 1, 2, and 3 selective inhibitors for HIV latency reactivation.
Bioorg Med Chem Lett
; 30(13): 127197, 2020 07 01.
Article
in English
| MEDLINE | ID: mdl-32331932
2.
Potent, non-covalent reversible BTK inhibitors with 8-amino-imidazo[1,5-a]pyrazine core featuring 3-position bicyclic ring substitutes.
Bioorg Med Chem Lett
; 30(17): 127390, 2020 09 01.
Article
in English
| MEDLINE | ID: mdl-32738973
3.
Chemoselective Peptide Modification via Photocatalytic Tryptophan ß-Position Conjugation.
J Am Chem Soc
; 140(22): 6797-6800, 2018 06 06.
Article
in English
| MEDLINE | ID: mdl-29762027
4.
Discovery of novel BTK inhibitors with carboxylic acids.
Bioorg Med Chem Lett
; 27(6): 1471-1477, 2017 03 15.
Article
in English
| MEDLINE | ID: mdl-28254166
5.
Discovery of 3-morpholino-imidazole[1,5-a]pyrazine BTK inhibitors for rheumatoid arthritis.
Bioorg Med Chem Lett
; 27(16): 3939-3943, 2017 08 15.
Article
in English
| MEDLINE | ID: mdl-28720503
6.
Use of molecular modeling aided design to dial out hERG liability in adenosine A(2A) receptor antagonists.
Bioorg Med Chem Lett
; 25(15): 2958-62, 2015 Aug 01.
Article
in English
| MEDLINE | ID: mdl-26048804
7.
Quality by design (QbD) of amide isosteres: 5,5-Disubstituted isoxazolines as potent CRTh2 antagonists with favorable pharmacokinetic and drug-like properties.
Bioorg Med Chem Lett
; 24(6): 1615-20, 2014 Mar 15.
Article
in English
| MEDLINE | ID: mdl-24556380
8.
Synthesis of HDAC Inhibitor Libraries via Microscale Workflow.
ACS Med Chem Lett
; 12(3): 337-342, 2021 Mar 11.
Article
in English
| MEDLINE | ID: mdl-33738059
9.
Discovery of Ethyl Ketone-Based Highly Selective HDACs 1, 2, 3 Inhibitors for HIV Latency Reactivation with Minimum Cellular Potency Serum Shift and Reduced hERG Activity.
J Med Chem
; 64(8): 4709-4729, 2021 04 22.
Article
in English
| MEDLINE | ID: mdl-33797924
10.
Discovery of Highly Selective and Potent HDAC3 Inhibitors Based on a 2-Substituted Benzamide Zinc Binding Group.
ACS Med Chem Lett
; 11(12): 2476-2483, 2020 Dec 10.
Article
in English
| MEDLINE | ID: mdl-33335670
11.
Selective Class I HDAC Inhibitors Based on Aryl Ketone Zinc Binding Induce HIV-1 Protein for Clearance.
ACS Med Chem Lett
; 11(7): 1476-1483, 2020 Jul 09.
Article
in English
| MEDLINE | ID: mdl-32676157
12.
3,4-Diamino-1,2,5-thiadiazole as potent and selective CXCR2 antagonists.
Bioorg Med Chem Lett
; 19(5): 1434-7, 2009 Mar 01.
Article
in English
| MEDLINE | ID: mdl-19200721
13.
Fluoroalkyl alpha side chain containing 3,4-diamino-cyclobutenediones as potent and orally bioavailable CXCR2-CXCR1 dual antagonists.
Bioorg Med Chem Lett
; 19(5): 1431-3, 2009 Mar 01.
Article
in English
| MEDLINE | ID: mdl-19196511
14.
Diaminocyclobutenediones as potent and orally bioavailable CXCR2 receptor antagonists: SAR in the phenolic amide region.
Bioorg Med Chem Lett
; 19(15): 4446-9, 2009 Aug 01.
Article
in English
| MEDLINE | ID: mdl-19525110
15.
3,4-Diamino-2,5-thiadiazole-1-oxides as potent CXCR2/CXCR1 antagonists.
Bioorg Med Chem Lett
; 18(1): 228-31, 2008 Jan 01.
Article
in English
| MEDLINE | ID: mdl-18006311
16.
Synthesis and structure-activity relationships of heteroaryl substituted-3,4-diamino-3-cyclobut-3-ene-1,2-dione CXCR2/CXCR1 receptor antagonists.
Bioorg Med Chem Lett
; 18(4): 1318-22, 2008 Feb 15.
Article
in English
| MEDLINE | ID: mdl-18242983
17.
Synthesis of the oxygenated pactamycin core.
Org Lett
; 9(7): 1359-62, 2007 Mar 29.
Article
in English
| MEDLINE | ID: mdl-17338541
18.
Discovery of 2-hydroxy-N,N-dimethyl-3-{2-[[(R)-1-(5- methylfuran-2-yl)propyl]amino]-3,4-dioxocyclobut-1-enylamino}benzamide (SCH 527123): a potent, orally bioavailable CXCR2/CXCR1 receptor antagonist.
J Med Chem
; 49(26): 7603-6, 2006 Dec 28.
Article
in English
| MEDLINE | ID: mdl-17181143
19.
Discovery of 8-Amino-imidazo[1,5-a]pyrazines as Reversible BTK Inhibitors for the Treatment of Rheumatoid Arthritis.
ACS Med Chem Lett
; 7(2): 198-203, 2016 Feb 11.
Article
in English
| MEDLINE | ID: mdl-26985298
20.
CXCR2 modulators: a patent review (2009 - 2013).
Expert Opin Ther Pat
; 24(5): 519-34, 2014 May.
Article
in English
| MEDLINE | ID: mdl-24555661